NewGenIvf (NIVF) Invested Capital (2022 - 2025)

NewGenIvf has disclosed Invested Capital across 4 years of filings, most recently posting $26.9 million for Q4 2025.

• In Q4 2025, Invested Capital rose 2680.35% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (up 2680.35% YoY), while the FY2025 annual figure was $26.9 million, up 2680.35% from the prior year.
• Invested Capital slipped to $26.9 million in Q4 2025, from $29376.1 billion in the prior quarter.
• Over the last five years, Invested Capital for NIVF reached as high as $29376.1 billion in Q3 2025 and fell as low as -$1.0 million in Q4 2024.
• The 4-year median for Invested Capital is $6.6 million (2023), against an average of $4896.0 billion.
• Annual changes were most pronounced in 2024 — Invested Capital sank 129.18% — and 2025, when it soared 2680.35%.
• A 4-year view of Invested Capital shows it stood at $527521.0 in 2022, then soared by 577.07% to $3.6 million in 2023, then slumped by 129.18% to -$1.0 million in 2024, then soared by 2680.35% to $26.9 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $26.9 million, $29376.1 billion, and $9.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.